Dirk Strunk

Dirk Strunk is a full Professor at the Institute for Experimental and Clinical Cell Therapy, Paracelsus Private Medical University, Salzburg. With over 526 publications and 16 projects, he leads cutting-edge research in regenerative medicine, extracellular vesicles, and gene editing. His work spans stem cell biology, immunomodulation, and biomedical engineering.

Scientific awards include the

• Erwin Domanig Prize (2005, 2009)
• Magna Cum Laude Thesis (Charité University Berlin, 1989)
• Otto Kraupp Prize (2006)
• Sanofi Aventis Prize (2007)

His research activities in extracellular vesicle analysis and regenerative therapies have produced significant contributions in myocardial infarction models, multiple sclerosis immunology, and skin disorder gene editing. Current projects like NEXGEN-PD (Parkinson's disease vaccine platform) and HEAL (iPSC-cardiomyocyte therapy) highlight his translational focus.